Clinical Trial Update: An Open-label, Single Arm, Phase 2 Study to Evaluate ABT-450/r/ABT-267 and ABT-333 With Ribavirin (RBV) in Adults With Genotype 1 HCV Infection Taking Methadone or Buprenorphine [Phase 2]

View source ↗

Summary

An open-label, single-arm Phase 2 study evaluating ABT-450/r/ABT-267 and ABT-333 with ribavirin in adults with genotype 1 chronic hepatitis C. The trial complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• ABT-333 (ABT-333)
• ABT-450/r/ABT-267
• Ribavirin (ribavirin)

Snippet

Sponsor: AbbVie | Conditions: Chronic Hepatitis C Infection, Chronic Hepatitis C | Phase 2 | Status: COMPLETED | Results posted: 2015-01-06